Four Outstanding Professors Granted Highest Academic Designation
Distinguished University Professor status is the highest academic designation granted by the MUSC Board of Trustees. Prior to the induction of the four outstanding individuals (Drs. Brady, Creasman, Kraft and Reves) by the MUSC Board of Trustees on February 12, 2010, only twenty-eight individuals had received this designation in the history of the University. Distinguished University Professor status is granted to individuals who have (1) been transformative leaders in their own field(s) of scholarship, (2) contributed in substantial ways to the enrichment of our university, and (3) made major career contributions during an extended time at MUSC.
| ||Kathleen Brady, MD, PhD, is an outstanding clinical and translational scientist, mentor and leader. Author of over 270 full-length publications, she is recognized internationally as a leader in the field of addiction. A graduate of our medical school, Dr. Brady has contributed to our university since 1983. A Professor of Psychiatry and Behavioral Medicine, she spearheaded MUSC’s successful renewal of NIH support for the General Clinical Research Center, and served as Principal Investigator and Director of the South Carolina Clinical and Translational Research Institute (SCTR), which was awarded an NIH Clinical and Translational Science Award (CTSA) last year.|
|Andrew S. Kraft, MD, is a brilliant clinician-scientist, administrator and leader. He is widely recognized as an international leader in unraveling the cell biology and biochemistry of cancer, and has published nearly 130 full-length manuscripts. Dr. Kraft’s lifetime ambition is to cure all forms of cancer. He joined MUSC as Director of the Hollings Cancer Center, Professor of Medicine, and William H. Folk, MD, Endowed Professor in 2004. He has orchestrated a remarkable expansion of the scientific enterprise, clinical services, community outreach and facilities of the Hollings Cancer Center. He spearheaded our successful application for designation by the National Cancer Institute of the NIH, which was granted in 2009.|
|William Creasman, MD, is an internationally recognized leader in the field of Gynecological Oncology, a skillful clinician and surgeon, and astute academic leader and mentor. He has made remarkable contributions to cancer prevention and control, translational research, and technical advances in surgical techniques for treating gynecological malignancies. He joined MUSC as Chair of the Department of Obstetrics and Gynecology in 1986; he has held the first Sims-Hester Endowed Chair and the J. Marion Sims Chair in Obstetrics and Gynecology. Author of 400 manuscripts, chapters, reviews and monographs, Dr. Creasman’s textbook, Clinical Gynecologic Oncology, is now in its seventh edition as the definitive textbook in its field.|
|Joseph G. (Jerry) Reves, MD, is a superior clinician, clinical investigator, teacher, administrator and leader. A native Charlestonian and graduate of our medical school, he rejoined MUSC as the Dean of the College of Medicine, Professor of Anesthesia and Perioperative Medicine, and Vice President for Medical Affairs in 2000. Under his leadership, the College of Medicine has undergone tremendous growth, with focuses on excellence in all of our missions. He has presided over remarkable growth in our clinical and research enterprises, has been a leader in enhancing diversity of our student population, and has built a culture of financial accountability. Author of over 275 full-length publications, he is internationally recognized for his work on cognitive function after cardiac surgery, aging and anesthesia, and the use of simulation modalities in medical education and practitioner training.|